Zifi 400 Tablet contains Cefixime 400 mg, a third-generation cephalosporin antibiotic effective against a broad spectrum of Gram-positive and Gram-negative bacteria. It functions by inhibiting bacterial cell wall synthesis, leading to cell lysis and death. Zifi 400 is indicated for the treatment of various bacterial infections including respiratory tract infections such as bronchitis and pneumonia, urinary tract infections, otitis media, pharyngitis, and gonorrhea. It is particularly useful in cases where resistance to other antibiotics is suspected or confirmed. The tablet is administered orally, with dosage and duration determined based on the severity and type of infection, as well as patient-specific factors such as age and renal function. Common adverse effects may include gastrointestinal disturbances like diarrhea, nausea, abdominal pain, and allergic reactions such as rash or pruritus. Caution is advised in patients with a history of hypersensitivity to cephalosporins or penicillins. Renal impairment requires dose adjustment to prevent accumulation and toxicity. Zifi 400 should be used under medical supervision, ensuring the full course is completed to prevent bacterial resistance. It is contraindicated in viral infections and should not be used without confirmed bacterial etiology.